Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 15,935,241
- Share change
- -304,346
- Total reported value
- $79,992,923
- Price per share
- $5.02
- Number of holders
- 29
- Value change
- -$1,598,866
- Number of buys
- 11
- Number of sells
- 11
Report period
Q4 2021
Institutions
29
Top holders
10
SCPH full security history
Newer quarter: Q1 2022
Previous quarter: Q3 2021
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 810648105
Recent filing periods:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
9%
|
4,797,148
|
$31,901,000 | — | 30 Sep 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
7.2%
|
3,831,474
|
$25,479,000 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.1%
|
2,731,170
|
$18,162,000 | — | 30 Sep 2021 | |
| AIGH Capital Management LLC |
13F
|
Company |
2.3%
|
1,234,121
|
$8,207,000 | — | 30 Sep 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.7%
|
901,362
|
$5,994,000 | — | 30 Sep 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
1.5%
|
792,421
|
$5,270,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
617,048
|
$4,103,000 | — | 30 Sep 2021 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.56%
|
300,760
|
$2,000,000 | — | 30 Sep 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.36%
|
193,586
|
$1,287,000 | — | 30 Sep 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
132,200
|
$879,000 | — | 30 Sep 2021 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.19%
|
102,207
|
$680,000 | — | 30 Sep 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
86,635
|
$576,000 | — | 30 Sep 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.15%
|
79,265
|
$527,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
71,223
|
$473,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
69,993
|
$465,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.11%
|
58,086
|
$387,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
50,110
|
$333,000 | — | 30 Sep 2021 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.07%
|
36,989
|
$246,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
34,603
|
$230,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
33,542
|
$223,000 | — | 30 Sep 2021 | |
| Ergoteles LLC |
13F
|
Company |
0.05%
|
27,116
|
$180,000 | — | 30 Sep 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.03%
|
16,189
|
$107,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
14,000
|
$93,000 | — | 30 Sep 2021 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
10,696
|
$71,000 | — | 30 Sep 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
3,857
|
$25,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,154
|
$8,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
843
|
$6,000 | — | 30 Sep 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
814
|
$5,000 | — | 30 Sep 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
106
|
$705 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
79
|
$1,000 | — | 30 Sep 2021 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q4 2021
As of 31 Dec 2021,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,935,241 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, RA CAPITAL MANAGEMENT, L.P., AIGH Capital Management LLC, Ikarian Capital, LLC, VANGUARD GROUP INC, J. Goldman & Co LP, Worth Venture Partners, LLC, RENAISSANCE TECHNOLOGIES LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
29
Q4 2021 holders
29
Holder diff
0
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.